ImmunityBio, Inc. IBRX
At closeNov 13, 2026, 5:27 PM EST
After hours · Nov 13, 5:27 PM ET
- YTD
- +204.04%
- 1 year
- +201.00%
Discussion (3521)
Sign in to join the discussion
Ray Bratton
Go away you make me. Lol
We need MSM cnbc foxb something like that but they are not permitted to cover ImmunityBio Anktiva and BioShield threaten their advertising revenue from the BIG BAD EVIL BIG PHARMA!!!!
"The bacterial genotoxin colibactin interferes with the eukaryotic cell cycle by causing dsDNA breaks. It has been linked to bacterially induced colorectal cancer in humans. Colibactin"
Bioshield works by controlling or eliminating the colibactin bacterial colon infection, is my bet. I wonder if lynch syndrome patients have an increased risk or more sever type of colibactin infections?
I wonder how many cancers are related to bacterial and viral infections!
COVID SARS-CoV-2 is most likely oncogenic. Isn't that just special!
"The bacterial genotoxin colibactin interferes with the eukaryotic cell cycle by causing dsDNA breaks. It has been linked to bacterially induced colorectal cancer in humans. Colibactin"
Bioshield works by controlling or eliminating the colibactin bacterial colon infection, is my bet. I wonder if lynch syndrome patients have an increased risk or more sever type of colibactin infections?
I wonder how many cancers are related to bacterial and viral infections!
COVID SARS-CoV-2 is most likely oncogenic. Isn't that just special!
Write MSM get us some press to get the stock rocking ?
We need mainstream PR write to them attach links
Trump plays chess
BioShied and Anktiva are the most exiting thing I have see on medicine in 40 plus years! It's like when Penicillin arrived!
